China Ophthalmic Eye Droppers Market Size & Outlook
China ophthalmic eye droppers market, 2018-2030 (US$M)
Related Markets
China ophthalmic eye droppers market highlights
- The China ophthalmic eye droppers market generated a revenue of USD 347.1 million in 2023 and is expected to reach USD 538.0 million by 2030.
- The China market is expected to grow at a CAGR of 6.5% from 2024 to 2030.
- In terms of segment, preserved multi-dose eye droppers was the largest revenue generating type in 2023.
- Preserved multi-dose eye droppers is the most lucrative type segment registering the fastest growth during the forecast period.
Ophthalmic eye droppers market data book summary
| Market revenue in 2023 | USD 347.1 million |
| Market revenue in 2030 | USD 538.0 million |
| Growth rate | 6.5% (CAGR from 2023 to 2030) |
| Largest segment | Preserved multi-dose eye droppers |
| Fastest growing segment | Preserved multi-dose eye droppers |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Unidose eye droppers, Preserved multi-dose eye droppers, Preservative-free multi-dose eye droppers |
| Key market players worldwide | AptarGroup Inc, Silgan Holdings Inc, Alcon Inc, Pfizer Inc, Bausch & Lomb Corp, Novartis AG ADR, AbbVie Inc |
Other key industry trends
- In terms of revenue, China accounted for 2.6% of the global ophthalmic eye droppers market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan ophthalmic eye droppers market is projected to lead the regional market in terms of revenue in 2030.
- South Korea is the fastest growing regional market in Asia Pacific and is projected to reach USD 270.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Ophthalmic Eye Droppers Market Scope
Ophthalmic Eye Droppers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China ophthalmic eye droppers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic eye droppers market will help companies and investors design strategic landscapes.
Preserved multi-dose eye droppers was the largest segment with a revenue share of 49.99% in 2023. Horizon Databook has segmented the China ophthalmic eye droppers market based on unidose eye droppers, preserved multi-dose eye droppers, preservative-free multi-dose eye droppers covering the revenue growth of each sub-segment from 2018 to 2030.
The prevalence of ophthalmic conditions, such as DED, is anticipated to increase significantly over the coming years due to the overuse of visual display terminals. Therefore, the high burden of ophthalmic conditions is expected to increase the demand for eye droppers.
Furthermore, the growing geriatric population is expected to further contribute to market growth, as they are more susceptible to various eye diseases & may require surgery. According to WHO, in 2019, there were 254 million individuals aged 60 years & above and 176 million aged 65 years & above.
Reasons to subscribe to China ophthalmic eye droppers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China ophthalmic eye droppers market databook
-
Our clientele includes a mix of ophthalmic eye droppers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China ophthalmic eye droppers market , including forecasts for subscribers. This country databook contains high-level insights into China ophthalmic eye droppers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China ophthalmic eye droppers market size, by type, 2018-2030 (US$M)
China Ophthalmic Eye Droppers Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
